ConductScience.org, home

Paper6986949

Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects.

Man in 't Veld AJ and 4 others. Br Med J, 1980. Cited by 67 papers, by iCite.

Cite this record

ConductScience Library. Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects. Papers, record 6986949. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6986949

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects.
PubMed
Journal
Br Med J
PubMed
Year
1980
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
67
iCite
Relative citation ratio, by iCite
3.24
iCite
Revised in PubMed
2019-05-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Man in 't Veld AJA J
2Schicht IMI M
3Derkx FHF H
4de Bruyn JHJ H
5Schalekamp MAM A

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood PressureMajor topic
CaptoprilMajor topic
NephrectomyMajor topic
ProlineMajor topic
Adult
Body Fluids
Clinical Trials as Topic
Depression, Chemical
Double-Blind Method
Female
Humans
Male
Middle Aged
Random Allocation
Renal Dialysis
Renin

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15761846Renin activity in aortic tissue of rats.Can J Physiol Pharmacol1969https://conductscience.org/library/papers/5761846PubMed
290216Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.Lancet1979https://conductscience.org/library/papers/90216PubMed
34127309Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure.Lancet1973https://conductscience.org/library/papers/4127309PubMed
4234806Angiotensin I converting enzyme.Circ Res1975https://conductscience.org/library/papers/234806PubMed
5235218Inhibition of angiotensin conversion and prevention of renal hypertension.Am J Physiol1975https://conductscience.org/library/papers/235218PubMed
6168877Subcellular localization of pulmonary antiotensin-converting enzyme (kininase II).Biochem J1975https://conductscience.org/library/papers/168877PubMed
7174834The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects.Circulation1976https://conductscience.org/library/papers/174834PubMed
8939003Response of aldosterone and blood pressure to angiotensin II infusion in anephric man. Effect of sodium deprivation.Circ Res1976https://conductscience.org/library/papers/939003PubMed
9980059Reciprocal relation between renin dependency and sodium dependency in essential hypertension.N Engl J Med1976https://conductscience.org/library/papers/980059PubMed
10185903Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.Am J Med1976https://conductscience.org/library/papers/185903PubMed
11190537Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.N Engl J Med1977https://conductscience.org/library/papers/190537PubMed
1274464Inactive renin in human plasma.Lancet1976https://conductscience.org/library/papers/74464PubMed
13195203Accentuated vascular and endocrine response to SQ 20881 in hypertension.N Engl J Med1977https://conductscience.org/library/papers/195203PubMed
14844262Blood pressure response of nephrectomized hypertensive rats to converting enzyme inhibition: evidence for persistent vascular renin activity.Clin Sci Mol Med1977https://conductscience.org/library/papers/844262PubMed
15205788Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man.N Engl J Med1978https://conductscience.org/library/papers/205788PubMed
16148934Surface-mediated reactions in the formation of thrombin, plasmin and kallikrein.Br Med Bull1978https://conductscience.org/library/papers/148934PubMed
1780634Innappropriate renin secretion unmasked by captopril (SQ 14 225) in hypertension of chronic renal failure.Lancet1978https://conductscience.org/library/papers/80634PubMed
18213296Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats.Eur J Pharmacol1978https://conductscience.org/library/papers/213296PubMed
19214268Haemodynamics of orally-active converting enzyme inhibitor (SQ 14225) in hypertensive patients.Clin Sci Mol Med1978https://conductscience.org/library/papers/214268PubMed
20214818Captopril (SQ 14,225) (D-3-mercapto-2-methylpropranoyl-L-proline): a novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent.Prog Cardiovasc Dis1978https://conductscience.org/library/papers/214818PubMed

See all 24 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.

PMIDTitleJournalYearIn PapersSource
32675281Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials.Clin J Am Soc Nephrol2020https://conductscience.org/library/papers/32675281PubMed
26030651
Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study).
PLoS One2015https://conductscience.org/library/papers/26030651PubMed
21264001New drugs for the treatment of hypertension: where do they fit?Can Fam Physician1987https://conductscience.org/library/papers/21264001PubMed
9114905The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril.Br J Clin Pharmacol1993https://conductscience.org/library/papers/9114905PubMed
8894524Optimal dosage of ACE inhibitors in older patients.Drugs Aging1996https://conductscience.org/library/papers/8894524PubMed
7833591Changes in the renin-angiotensin-aldosterone axis in later life.Drugs Aging1994https://conductscience.org/library/papers/7833591PubMed
7026256Haemodynamic profile of captopril treatment in various forms of hypertension.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7026256PubMed
7009133Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.Drugs1980https://conductscience.org/library/papers/7009133PubMed
7008822Attenuation by SQ 14,255 (captopril) of the vascular response to noradrenaline in the rate isolated kidney.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7008822PubMed
6992919Absence of blood-pressure lowering effect of captopril in anephric patients.Br Med J1980https://conductscience.org/library/papers/6992919PubMed
6384268Local generation of angiotensin II as a mechanism of regulation of peripheral vascular tone in the rat.J Clin Invest1984https://conductscience.org/library/papers/6384268PubMed
6316248Inhibitors of the angiotensin I converting enzyme as antihypertensive drugs.Pharm Weekbl Sci1983https://conductscience.org/library/papers/6316248PubMed
6170971Hormonal and blood pressure changes during converting enzyme inhibition by teprotide.Postgrad Med J1981https://conductscience.org/library/papers/6170971PubMed
6159943Inhibitors of angiotensin I converting enzyme for treating hypertension.Br Med J1980https://conductscience.org/library/papers/6159943PubMed
3580258Factors in the choice of antihypertensive therapy.Br J Clin Pharmacol1987https://conductscience.org/library/papers/3580258PubMed
3119118Angiotensin converting enzyme inhibitors in the elderly.Br Med J (Clin Res Ed)1987https://conductscience.org/library/papers/3119118PubMed
3030762The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients.Eur J Clin Pharmacol1987https://conductscience.org/library/papers/3030762PubMed
2078997Newer ACE inhibitors. A look at the future.Drugs1990https://conductscience.org/library/papers/2078997PubMed
2062770Hypertension.Postgrad Med J1991https://conductscience.org/library/papers/2062770PubMed
1852662Medicine in the elderly.Postgrad Med J1991https://conductscience.org/library/papers/1852662PubMed

See all 21 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6986949

GET https://conductscience.org/api/papers/v1/6986949/references?page=2